425 related articles for article (PubMed ID: 25124924)
1. Prolyl isomerase Pin1 in cancer.
Lu Z; Hunter T
Cell Res; 2014 Sep; 24(9):1033-49. PubMed ID: 25124924
[TBL] [Abstract][Full Text] [Related]
2. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
[TBL] [Abstract][Full Text] [Related]
3. The peptidyl-prolyl isomerase Pin1.
Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
[TBL] [Abstract][Full Text] [Related]
4. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins.
Shen M; Stukenberg PT; Kirschner MW; Lu KP
Genes Dev; 1998 Mar; 12(5):706-20. PubMed ID: 9499405
[TBL] [Abstract][Full Text] [Related]
5. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
Stifani S
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
[TBL] [Abstract][Full Text] [Related]
6. Prolyl isomerase Pin1 regulates transcription factor LSF (TFCP2) by facilitating dephosphorylation at two serine-proline motifs.
Saxena UH; Owens L; Graham JR; Cooper GM; Hansen U
J Biol Chem; 2010 Oct; 285(41):31139-47. PubMed ID: 20682773
[TBL] [Abstract][Full Text] [Related]
7. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
Ryo A; Liou YC; Lu KP; Wulf G
J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
[TBL] [Abstract][Full Text] [Related]
8. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.
Liou YC; Zhou XZ; Lu KP
Trends Biochem Sci; 2011 Oct; 36(10):501-14. PubMed ID: 21852138
[TBL] [Abstract][Full Text] [Related]
9. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.
Zhou XZ; Kops O; Werner A; Lu PJ; Shen M; Stoller G; Küllertz G; Stark M; Fischer G; Lu KP
Mol Cell; 2000 Oct; 6(4):873-83. PubMed ID: 11090625
[TBL] [Abstract][Full Text] [Related]
10. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx.
Ryo A; Hirai A; Nishi M; Liou YC; Perrem K; Lin SC; Hirano H; Lee SW; Aoki I
J Biol Chem; 2007 Dec; 282(50):36671-81. PubMed ID: 17938171
[TBL] [Abstract][Full Text] [Related]
11. Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase.
Chen XR; Igumenova TI
Adv Biol Regul; 2023 Jan; 87():100938. PubMed ID: 36496344
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation-dependent prolyl isomerization: a novel cell cycle regulatory mechanism.
Lu KP
Prog Cell Cycle Res; 2000; 4():83-96. PubMed ID: 10740817
[TBL] [Abstract][Full Text] [Related]
13. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease.
Takahashi K; Uchida C; Shin RW; Shimazaki K; Uchida T
Cell Mol Life Sci; 2008 Feb; 65(3):359-75. PubMed ID: 17965833
[TBL] [Abstract][Full Text] [Related]
14. The yeast Ess1 prolyl isomerase controls Swi6 and Whi5 nuclear localization.
Atencio D; Barnes C; Duncan TM; Willis IM; Hanes SD
G3 (Bethesda); 2014 Mar; 4(3):523-37. PubMed ID: 24470217
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
16. Recent advances of Pin1 inhibitors as potential anticancer agents.
Bai Y; Yuan Z; Yuan S; He Z
Bioorg Chem; 2024 Mar; 144():107171. PubMed ID: 38325131
[TBL] [Abstract][Full Text] [Related]
17. Proline isomerase Pin1 represses terminal differentiation and myocyte enhancer factor 2C function in skeletal muscle cells.
Magli A; Angelelli C; Ganassi M; Baruffaldi F; Matafora V; Battini R; Bachi A; Messina G; Rustighi A; Del Sal G; Ferrari S; Molinari S
J Biol Chem; 2010 Nov; 285(45):34518-27. PubMed ID: 20801874
[TBL] [Abstract][Full Text] [Related]
18. Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1.
Guillen-Quispe YN; Kim SJ; Saeidi S; Zhou T; Zheng J; Kim SH; Fang X; Chelakkot C; Rios-Castillo ME; Shin YK; Surh YJ
Free Radic Biol Med; 2023 Oct; 207():296-307. PubMed ID: 37473874
[TBL] [Abstract][Full Text] [Related]
19. The metabolic crosstalk between PIN1 and the tumour microenvironment.
Caligiuri I; Vincenzo C; Asano T; Kumar V; Rizzolio F
Semin Cancer Biol; 2023 Jun; 91():143-157. PubMed ID: 36871635
[TBL] [Abstract][Full Text] [Related]
20. Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.
Kim G; Kim JY; Choi HS
Biol Pharm Bull; 2015; 38(7):975-9. PubMed ID: 26133706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
